AsymBio’s Post

🔬 At the upcoming Copenhagen Bioprocessing Summit, Rasmus Pedersen will present on a crucial topic: "Is our industry really industrialized?" He will be discussing how biopharmaceutical manufacturing often lacks the uniformity seen in other industries like automotive or semiconductors. Each pipeline's unique processes and company-specific approaches can create significant bottlenecks, especially when scaling or transferring programs. However, there is a common core we can leverage to industrialize biologics more effectively. At FUJIFILM Diosynth Biotechnologies, we are addressing these challenges head-on with our modular KojoX™ approach. This framework allows us to create a global network of standardized process and manufacturing capabilities, ensuring consistent, high-performance delivery across all sites, scales, modalities, and drug life cycle phases. Learn more on May 28th at Copenhagen Bioprocessing Summit about how we're pushing the boundaries of biopharmaceutical industrialization to improve patient access worldwide. https://lnkd.in/eS7UJk_G #KojoX #Bioprocessing #Biologics #Copenhagen

As industry demand for the development of novel therapies increases, the hurdles of development have shifted toward smaller biopharmaceutical companies, university spinoffs, and/or virtual startups. However, a few succeed in advancing a molecule with therapeutic potential. While speed to market remains critical, the industry is increasingly focused on maximizing the effectiveness of early-stage candidate assessments to predict a given molecule’s chances of success before investing heavily in that molecule. To this end, Samsung Biologics created DEVELOPICK™. Learn more about DEVELOPICK™ and its capabilities in this recent case study: https://hubs.ly/Q02hN3pH0 – #BioTurns10 #GenerisBIO #SamsungBiologics #DEVELOPICK #biologics #biomanufacturing #pharmaceuticals

We’re called Custom Biologics for a reason. 🧪💉🌿💊 #Biologics are complex, making these types of drugs difficult to characterize and identify. It's also more difficult to generate the scientific evidence needed to support drug submissions. The good news is, we specialize in this and have been performing this work for 20+ years. If you require customized bioassays for biologics, explore our capabilities: https://lnkd.in/g5YYMCuT #biotherapeutics #bioassays #bioanalysis #biotech

🌟 Academic Labs: Fuel Your Life-Saving Research with Exclusive Deals! 🌟 Pharmaceutical and biopharmaceutical scientists, elevate your lab's capabilities with our top-tier instrument packages! 💊🔬 Whether you're working on antibody research, drug formulations, or drug delivery systems, we have bundled packages designed to enhance your lab's precision and efficiency. https://lnkd.in/eF9ek8_D 🧪 Explore top-of-the-line instrumentation for everything from drug composition to biologics stability. No grant? No problem—our discounts ensure your research never slows down. Dive into these packages to pair techniques that optimize your workflows and accelerate results! #PharmaResearch #Biologics #AcademicExcellence #DrugDevelopment

More with less in biopharmaceutical manufacturing – that was the focus of the panel discussion organized by Sartorius at #SwissBiotechDay. Thomas Villiger from the Hochschule für Life Sciences FHNW shared insights about process intensification, including innovations in continuous chromatography. His team is working on technologies that not only increase yields of biologics but also reduce the amount of material and energy needed to produce them. More efficient processes can contribute to sustainability as well as ultimately reducing the cost of biologic therapies for patients and payers, toward greater accessibility. #biomanufacting #processintensification #continuouschromatography #biologics #sustainability #accessibility

📢 Unlocking Biologics: Three Smart Scaling Strategies! 🚀 Biologics manufacturers can scale production in three ways: scaling up, out, or down. 📈 Scaling up increases manufacturing volume but often needs significant investment. 🔄 Scaling out adds parallel lines, enhancing flexibility and response to market needs. 🔍 Scale-down models improve process understanding and mitigate risks before large investments. 💡 Each method should align with business strategies and market demands. #BioprocessUpdates #Biologics #BiologicsProduction #ManufacturingInnovation #ScaleUp #ScaleOut #ScaleDown #Pharmaceuticals #Biotech #ProductionStrategies #MarketFlexibility #InvestmentStrategies #ProcessOptimization #BiotechIndustry #CommercialScale #ManufacturingExcellence ▷ Read the full article here: 📎 https://lnkd.in/duX_j2Hc

Scaling up biologics production can be a complex and challenging journey, but it's a crucial step for bringing life-saving therapies to market. BioFocus delves into the essential strategies one should consider when preparing to scale up biologics manufacturing processes. This guide covers: • Streamlining bioprocess development • Optimizing production workflows • Ensuring quality and compliance • Leveraging innovative technologies Whether you're a biotech professional, a researcher, or just passionate about the future of medicine, this article is packed with valuable information to help you navigate the scaling-up process with confidence. Read the full article here: Essential Strategies for Scaling Up Biologics https://lnkd.in/eySccKfG #Biologics #Biotech #LifeSciences #Bioprocessing #Innovation #Healthcare #Pharmaceuticals #ScalingUp

The Future of #Biologics Supply: Are We Ready? Very Large-Scale Tanks or #ContinuousBiomanufacturing? Which approach will ensure cost-effective and accessible biotherapeutics? "It's really about making sure these miracle drugs are cost-effective and we can get them to patients because patients deserve our help." Join Brian Kelley of Vir Biotechnology and Randal Bass of Just-Evotec Biologics as they explore the future of antibody production and how we can ensure life-saving treatments reach those who need them. Watch now: https://hubs.ly/Q02MVkYm0 Stay ahead of the curve. Contact us at info@evotec.com to learn more. #ContinuousManufacturing #Biologics #Biotherapeutics

Mapping the binding sites of your products onto their protein targets provides critical information during your drug discovery phase. Photene's Carbene Footprinting service is a high-resolution and low-cost method of collecting this data. Check out this testimonial from Dr. Jonathan Hopper, VP Platforms & Founder of OMass Therapeutics, who used Carbene Footprinting data to help progress their drug discovery programme. Enquiries: protein.footprinting@nottingham.ac.uk Visit our new website: www.photene.co.uk #drugdiscovery #drugdevelopment #pharmaceutical #pharmaceuticals #antibody #antibodydiscovery #protac #molecularglue #epitopemapping #massspectrometry #science #chemistry #agrochemicals